<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33870098</PMID><DateCompleted><Year>2021</Year><Month>11</Month><Day>04</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2532-1900</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology</Title><ISOAbbreviation>Acta Myol</ISOAbbreviation></Journal><ArticleTitle>Coexistence of myasthenia gravis and amyotrophic lateral sclerosis in a Bosnian male: an unusual clinical presentation.</ArticleTitle><Pagination><StartPage>66</StartPage><EndPage>68</EndPage><MedlinePgn>66-68</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.36185/2532-1900-044</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Myasthenia gravis (MG) and amyotrophic lateral sclerosis (ALS) are two different diseases. The coexistence of both of them is extremely rare and represents a diagnostic challenge which requires thoughtful interpretation of clinical characteristics.</AbstractText><AbstractText Label="CASE REPORT" NlmCategory="METHODS">We present the case of a 46-year-old Bosnian male who developed ALS five months after MG. Diagnosis of MG was based on elevated titers of anti-AchR antibodies, positive edrophonium test, and decremental responses on a repetitive nerve stimulation test while the diagnosis of ALS was based on clinical and neurophysiological findings: upper motor neuron signs in the lumbar region, lower motor neuron signs in the bulbar and cervical regions, generalized fasciculations and muscle atrophy and progressive asymetric muscle weakness together with active and chronic denervation in the cervical and lumbosacral region determined by electromyoneurography.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The coexistence of MG and ALS is rare and request an adequate interpretation of clinical symptoms. The relationship between these two diseases in as interesting phenomen to present.</AbstractText><CopyrightInformation>&#xa9;2021 Gaetano Conte Academy - Mediterranean Society of Myology, Naples, Italy.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hodzic</LastName><ForeName>Renata</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Clinical Centre Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piric</LastName><ForeName>Nermina</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Clinical Centre Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zukic</LastName><ForeName>Sanela</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Clinical Centre Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cickusic</LastName><ForeName>Amela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, University Clinical Centre Tuzla, Bosnia and Herzegovina.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Acta Myol</MedlineTA><NlmUniqueID>9811169</NlmUniqueID><ISSNLinking>1128-2460</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017522" MajorTopicYN="N" Type="Geographic">Bosnia and Herzegovina</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009157" MajorTopicYN="N">Myasthenia Gravis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">coexistence</Keyword><Keyword MajorTopicYN="N">myasthenia gravis</Keyword></KeywordList><CoiStatement>Conflict of interest The Authors declare no conflict of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>10</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33870098</ArticleId><ArticleId IdType="pmc">PMC8033427</ArticleId><ArticleId IdType="doi">10.36185/2532-1900-044</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Palma E, Reyes-Ruiz JM, Lopergolo D, et al. . Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy. Proc Natl Acad Sci U S A 2016;113:3060-3065. https://doi.org/10.1073/pnas.1600251113 10.1073/pnas.1600251113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1600251113</ArticleId><ArticleId IdType="pmc">PMC4801305</ArticleId><ArticleId IdType="pubmed">26929355</ArticleId></ArticleIdList></Reference><Reference><Citation>del Mar Amador M, Vandenberghe N, Berhoune N, et al. . Unusual association of amyotrophic lateral sclerosis and myasthenia gravis: a dysregulation of the adaptive immune system? Neuromuscul Disord 2016;26:342-346. https://doi.org/10.1016/j.nmd.2016.03.004 10.1016/j.nmd.2016.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2016.03.004</ArticleId><ArticleId IdType="pubmed">27102004</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai H, Cui L, Guan Y, et al. . Amyotrophic lateral sclerosis and myasthenia gravis overlap syndrome: a review of two cases and the associated literature. Front Neurol 2017;8:218. https://doi.org/10.3389/fneur.2017.00218 10.3389/fneur.2017.00218</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00218</ArticleId><ArticleId IdType="pmc">PMC5439131</ArticleId><ArticleId IdType="pubmed">28588549</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita S, Fujimoto A, Mori Y, et al. . Coexistance of amyotrophic lateral sclerosis and myasthenia gravis. J Neuromuscul Dis 2014:1:111-115. PMID: 27858665</Citation><ArticleIdList><ArticleId IdType="pubmed">27858665</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph A, Drory V, Hardiman O, et al. . A revision of the El Escorial criteria, 2015. Amyotroph Lateral Scler Frototemporal Degener 2015;16:291-292. https://doi.org/10.3109/21678421.2015.1049183 10.3109/21678421.2015.1049183</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1049183</ArticleId><ArticleId IdType="pubmed">26121170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohta K, Shigemoto K, Kubo S, et al. . MuSK antibodies in AchR Ab-seropositive MG vs AchR Ab-seronegative MG. Neurology 2004;62:2132-2133. https://doi.org/10.1212/01.wnl.0000129274.12702.92 10.1212/01.wnl.0000129274.12702.92</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000129274.12702.92</ArticleId><ArticleId IdType="pubmed">15184636</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Goldacre R, Ramagopalan S, et al. . Autoimmune disease preceding amyotrophic lateral sclerosis: an epidemiological study. Neurology 2013;81:1222-1225. https://doi.org/10.1212/WNL.0b013e3182a6cc13 10.1212/WNL.0b013e3182a6cc13</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182a6cc13</ArticleId><ArticleId IdType="pmc">PMC3795611</ArticleId><ArticleId IdType="pubmed">23946298</ArticleId></ArticleIdList></Reference><Reference><Citation>Murai H, Yamashita N, Watanabe M, et al. . Characteristics of myasthenia gravis according to onset-age: Japanese nationwide survey. J Neurol Sci 2011;305:97-102. https://doi.org/10.1016/j.jns.2011.03.004 10.1016/j.jns.2011.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.03.004</ArticleId><ArticleId IdType="pubmed">21440910</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, Watanabe H, Ito M, et al. . Age of onset influences on wide-ranged clinical features of sporadic amyotrophic lateral sclerosis. J Neurol Sci 2009;276:163-169. https://doi.org/10.1016/j.jns.2008.09.024 10.1016/j.jns.2008.09.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.09.024</ArticleId><ArticleId IdType="pubmed">18962725</ArticleId></ArticleIdList></Reference><Reference><Citation>Naik KR, Saroja AO, Mahajan M. Unusual occurance of amyotrophic lateral sclerosis in myasthenia gravis. Amyotrophic Lateral Sclerosis 2012;13:477-478. https://doi.org/10.3109/17482968.2012.711836 10.3109/17482968.2012.711836</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.711836</ArticleId><ArticleId IdType="pubmed">22876863</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawicka E, Bojakowski J. Syndrome of amyotrophic lateral sclerosis after thymectomy perfomed for myasthenic syndrome. Neurol Neurochir Pol 1985;19:43-47. PMID: 4022238</Citation><ArticleIdList><ArticleId IdType="pubmed">4022238</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilmont V, Cadot B, Vezin E, et al. . Dynein disruption perturbs post-synaptic components and contributes to impaired MuSK clustering at the NMJ: implication in ALS. Sci Rep 2016;6:27804.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4901269</ArticleId><ArticleId IdType="pubmed">27283349</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>